Literature DB >> 10558949

Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.

A Villaseñor-Sierra1, W M McShan, D Salmi, E L Kaplan, D R Johnson, D L Stevens.   

Abstract

Immunity to group A streptococci (GAS) is thought to be related to the acquisition of type-specific antibody directed against the M protein. However, recent work suggests that immunity may only be strain and not M-type specific. Therefore, susceptibility of 70 different GAS M-1 strains to opsonization and killing by convalescent sera was compared by using a highly sensitive chemiluminescence assay and by standard bactericidal assay. Sequencing of the emm1 gene in 10 strains with variable susceptibility to opsonization revealed 100% homology in 9 strains. Several substitutions in the N-terminal and 2 in the A3 repeat regions of strain CS-190 were associated with profound resistance to opsonization. Thus amino acid substitutions within different regions of the M-1 protein molecule may adversely affect opsonization by immune sera. In addition, non-M protein factors from identical M types influence susceptibility to phagocytosis. These findings may in part explain the persistently high prevalence of M-1 strains worldwide over the last 15 years.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558949     DOI: 10.1086/315120

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes.

Authors:  James B Dale; Thomas Penfound; Edna Y Chiang; Valerie Long; Stanford T Shulman; Bernard Beall
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Do cardiomyocytes mount an immune response to Group A Streptococcus?

Authors:  Zhi Li; Amy E Bryant; Stephanie M Hamilton; Clifford R Bayer; Yongsheng Ma; Dennis L Stevens
Journal:  Cytokine       Date:  2011-03-04       Impact factor: 3.861

3.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Authors:  Stephen B Beres; Gail L Sylva; Daniel E Sturdevant; Chanel N Granville; Mengyao Liu; Stacy M Ricklefs; Adeline R Whitney; Larye D Parkins; Nancy P Hoe; Gerald J Adams; Donald E Low; Frank R DeLeo; Allison McGeer; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

4.  Molecular characterization of a strain of group a streptococcus isolated from a patient with a psoas abscess.

Authors:  Susanna K P Lau; Patrick C Y Woo; Tak-ching Yim; Amanda P C To; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.

Authors:  Patrick R Shea; Amy L Ewbank; Javier H Gonzalez-Lugo; Alexandro J Martagon-Rosado; Juan C Martinez-Gutierrez; Hina A Rehman; Monica Serrano-Gonzalez; Nahuel Fittipaldi; Stephen B Beres; Anthony R Flores; Donald E Low; Barbara M Willey; James M Musser
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

6.  emm Type distribution pattern of group A streptococcus in north India: need for a new preventive approach.

Authors:  V Dhanda; R Kumar; J S Thakur; A Chakraborti
Journal:  Indian J Med Res       Date:  2010-12       Impact factor: 2.375

7.  Virulence potential of Group A streptococci isolated from throat cultures of children from north India.

Authors:  V Dhanda; H Vohra; R Kumar
Journal:  Indian J Med Res       Date:  2011-06       Impact factor: 2.375

8.  Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock.

Authors:  Robert G Ulrich
Journal:  J Immune Based Ther Vaccines       Date:  2008-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.